Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare Conference

Rhea-AI Summary

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) will have its Chairman and CEO, Dr. Scott Braunstein, participating in a fireside chat at the RBC Capital Markets 2024 Global Healthcare Conference on May 15 at 1:35 p.m. Eastern Time. The event will be accessible through Marinus' website, with a replay available for 90 days.

RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D., Chairman and Chief Executive Officer, will be participating in a fireside chat at the RBC Capital Markets 2024 Global Healthcare Conference.

The fireside chat will take place on Wednesday, May 15 beginning at 1:35 p.m. Eastern Time.

A link to the event can be accessed on the Investors and Media page of Marinus’ website at ir.marinuspharma.com/events-and-presentations. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 90 days.

About Marinus Pharmaceuticals
Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company first introduced FDA-approved prescription medication ZTALMY® (ganaxolone) oral suspension CV in the U.S. in 2022 and continues to invest in the potential of ganaxolone in IV and oral formulations to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings. For more information about Marinus visit www.marinuspharma.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240502100969/en/

Company

Investors and Media

Molly Cameron

Director, Corporate Communications & Investor Relations

Marinus Pharmaceuticals, Inc.

mcameron@marinuspharma.com

Source: Marinus Pharmaceuticals

FAQ

When is Marinus Pharmaceuticals participating in the RBC Capital Markets 2024 Global Healthcare Conference?

Marinus Pharmaceuticals will be participating on May 15 at 1:35 p.m. Eastern Time.

Who will be representing Marinus Pharmaceuticals at the conference?

Dr. Scott Braunstein, Chairman and CEO, will be representing Marinus Pharmaceuticals.

Where can I access the event?

The event can be accessed on the Investors and Media page of Marinus' website at ir.marinuspharma.com/events-and-presentations.

Will the webcast be available for replay?

Yes, a replay of the webcast will be available approximately two hours after the event and will be archived for up to 90 days.